litlas
Log inCreate account

Laurent Peyrin‐Biroulet

Active 2006–2025

Also published as
Laurent Peyrin-Biroulet
611
Papers
78,045
Citations
138
h-index
571
i10-index

Citations

Citations per year for Laurent Peyrin‐Biroulet1993: 2 citations1994: 5 citations1997: 1 citations2000: 1 citations2001: 1 citations2005: 2 citations2008: 12 citations2009: 38 citations2010: 54 citations2011: 142 citations2012: 237 citations2013: 338 citations2014: 373 citations2015: 424 citations2016: 536 citations2017: 621 citations2018: 601 citations2019: 2,596 citations2020: 3,486 citations2021: 3,432 citations2022: 3,396 citations2023: 3,324 citations2024: 5,526 citations2025: 2,879 citations2026: 55 citations1995–1996: no citations, so these years are not shown1998–1999: no citations, so these years are not shown2002–2004: no citations, so these years are not shown2006–2007: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,264 citing papers, 16.8% of this breakdownChina: 3,589 citing papers, 14.2% of this breakdownUnited Kingdom: 1,691 citing papers, 6.7% of this breakdownItaly: 1,587 citing papers, 6.3% of this breakdownCanada: 1,303 citing papers, 5.1% of this breakdownFrance: 1,266 citing papers, 5% of this breakdownGermany: 1,036 citing papers, 4.1% of this breakdownNetherlands: 817 citing papers, 3.2% of this breakdownSpain: 761 citing papers, 3% of this breakdownBelgium: 657 citing papers, 2.6% of this breakdownJapan: 640 citing papers, 2.5% of this breakdownAustralia: 593 citing papers, 2.3% of this breakdown
0%16.8%Other 28.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology54.9%
  • Medicine29.3%
  • Immunology and Microbiology7.9%
  • Neuroscience1.3%
  • Agricultural and Biological Sciences1.3%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Other4.2%

Topics

  • Inflammatory Bowel Disease17.9%
  • Microscopic Colitis5.5%
  • Gut microbiota and health4.9%
  • Rheumatoid Arthritis Research and Therapies2.5%
  • Autoimmune and Inflammatory Disorders2.1%
  • Biosimilars and Bioanalytical Methods1.7%
  • Other65.4%

Coauthors

All papers

Open in search
  1. Ulcerative colitis

    Authors: Catherine Le Berre, Sailish Honap, Laurent Peyrin‐Biroulet - The Lancet 2023 cited by 1,425

  2. Ulcerative colitis

    Authors: Ryan C. Ungaro, Saurabh Mehandru, Patrick B. Allen, Laurent Peyrin‐Biroulet, Jean‐Frédéric Colombel - The Lancet 2016 cited by 3,438

  3. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

    Authors: Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem A. Bemelman, Silvio Danese, Jean Yves Mary, David T. Rubin, Jean‐Frédéric Colombel, Laurent Peyrin‐Biroulet, Iris Dotan, María T. Abreu, Axel Dignaß - Gastroenterology 2021 cited by 2,666

  4. Ulcerative colitis

    Authors: Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N. Bernstein, Silvio Danese, Laurent Peyrin‐Biroulet, Toshifumi Hibi∥ - Nature Reviews Disease Primers 2020 cited by 1,568

  5. Crohn's disease

    Authors: Joana Torres, Saurabh Mehandru, Jean‐Frédéric Colombel, Laurent Peyrin‐Biroulet - The Lancet 2016 cited by 2,619

  6. Crohn’s disease

    Authors: Giulia Roda, Siew C. Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin‐Biroulet, Silvio Danese - Nature Reviews Disease Primers 2020 cited by 1,008

  7. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

    Authors: Bruce E. Sands, William J. Sandborn, Remo Panaccione, Christopher D. O’Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J. Adedokun, Katherine Li, Laurent Peyrin‐Biroulet, Gert Van Assche, Silvio Danese, Stephan R. Targan, María T. Abreu, Tadakazu Hisamatsu, Philippe Szapary, Colleen Marano - New England Journal of Medicine 2019 cited by 1,180

  8. Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

    Authors: Edward V. Loftus, Julián Panés, Ana P. Lacerda, Laurent Peyrin‐Biroulet, Geert D’Haens, Remo Panaccione, Walter Reinisch, Édouard Louis, Minhu Chen, Hiroshi Nakase, Jakob Begun, Brigid S. Boland, Charles D. Phillips, Mohamed‐Eslam F. Mohamed, Jianzhong Liu, Ziqian Geng, Tian Feng, Elena Dubcenco, Jean‐Frédéric Colombel - New England Journal of Medicine 2023 cited by 427

  9. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses

    Authors: Daniele Piovani, Silvio Danese, Laurent Peyrin‐Biroulet, Georgios K. Nikolopoulos, Theodore Lytras, Stefanos Bonovas - Gastroenterology 2019 cited by 788

  10. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    Authors: William J. Sandborn, Séverine Vermeire, Laurent Peyrin‐Biroulet, Marla C. Dubinsky, Julián Panés, Andrés Yarur, Timothy E. Ritter, Filip Baert, Stefan Schreiber, Sheldon Sloan, Fabio Cataldi, Kevin Shan, Christopher J. Rabbat, Michael Chiorean, Douglas C. Wolf, Bruce E. Sands, Geert D’Haens, Silvio Danese, Martina Goetsch, Brian G. Feagan - The Lancet 2023 cited by 333

  11. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    Authors: Geert D’Haens, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Marc Ferrante - The Lancet 2022 cited by 387

  12. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    Authors: Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 cited by 1,838

  13. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

    Authors: Brian G. Feagan, Silvio Danese, Edward V. Loftus, Séverine Vermeire, Stefan Schreiber, Timothy E. Ritter, Ronald Fogel, Rajiv Mehta, Sandeep Nijhawan, Radosław Kempiński, Rafał Filip, Ihor Hospodarskyy, Ursula Seidler, Frank Seibold, Ian Beales, Hyo Jong Kim, John McNally, Chohee Yun, Sally Zhao, Xiaopeng Liu, Chia‐Hsiang Hsueh, Chantal Tasset, R. Besuyen, Mamoru Watanabe, William J. Sandborn, Gerhard Rogler, Toshifumi Hibi∥, Laurent Peyrin‐Biroulet - The Lancet 2021 cited by 437

  14. Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis

    Authors: Juan S. Lasa, Pablo A. Olivera, Silvio Danese, Laurent Peyrin‐Biroulet - ˜The œLancet. Gastroenterology & hepatology 2021 cited by 370

  15. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    Authors: Marc Ferrante, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Geert D’Haens - The Lancet 2022 cited by 316

  16. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Authors: Fernando Gomollón, Axel Dignaß, Vito Annese, Herbert Tilg, Gert Van Assche, James O. Lindsay, Laurent Peyrin‐Biroulet, Garret Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almér, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Gerassimos J. Mantzaris, Fernando Rizzello, Stephan R. Vavricka, Paolo Gionchetti, on behalf of ECCO - Journal of Crohn s and Colitis 2016 cited by 2,071

  17. Iron deficiency anaemia

    Authors: Anthony Lopez, P. Cacoub, Iain C. Macdougall, Laurent Peyrin‐Biroulet - The Lancet 2015 cited by 1,475

  18. Revisiting fibrosis in inflammatory bowel disease: the gut thickens

    Authors: Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin‐Biroulet, Silvio Danese - Nature Reviews Gastroenterology & Hepatology 2021 cited by 233

  19. Inflammation and malnutrition in inflammatory bowel disease

    Authors: Sara Massironi, Chiara Viganò, Andrea Palermo, Lorena Pirola, Giacomo Mulinacci, Mariangela Allocca, Laurent Peyrin‐Biroulet, Silvio Danese - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 280

  20. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

    Authors: Bruce E. Sands, Laurent Peyrin‐Biroulet, Edward V. Loftus, Silvio Danese, Jean–Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers, Richard A. Lirio, Jeffrey D. Bornstein, Stefan Schreiber - New England Journal of Medicine 2019 cited by 725

  21. Application of Artificial Intelligence to Gastroenterology and Hepatology

    Authors: Catherine Le Berre, William J. Sandborn, Sabeur Aridhi, Marie‐Dominique Devignes, Laure Fournier, Malika Smaïl‐Tabbone, Silvio Danese, Laurent Peyrin‐Biroulet - Gastroenterology 2019 cited by 522

  22. Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies

    Authors: Tine Jess, Christine Rungoe, Laurent Peyrin‐Biroulet - Clinical Gastroenterology and Hepatology 2012 cited by 940

  23. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    Authors: William J. Sandborn, Brian G. Feagan, Edward V. Loftus, Laurent Peyrin‐Biroulet, Gert Van Assche, Geert D’Haens, Stefan Schreiber, Jean‐Frédéric Colombel, James D. Lewis, Subrata Ghosh, Alessandro Armuzzi, Ellen Scherl, Hans Herfarth, L.M. Vitale, Mohamed‐Eslam F. Mohamed, Ahmed A. Othman, Qian Zhou, Bidan Huang, Roopal Thakkar, Aileen L. Pangan, Ana P. Lacerda, Julián Panés - Gastroenterology 2020 cited by 317

  24. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

    Authors: Mathurin Fumery, Siddharth Singh, Parambir S. Dulai, Corinne Gower‐Rousseau, Laurent Peyrin‐Biroulet, William J. Sandborn - Clinical Gastroenterology and Hepatology 2017 cited by 491